Nonalcoholic steatohepatitis (NASH), recently renamed metabolic dysfunction-associated steatohepatitis (MASH) is a chronic liver disease causing hepatocellular injury and inflammatio...
Most patients with NAFLD and NASH are asymptomatic and are often diagnosed after incidentally noting elevated liver biochemical tests or hepatic steatosis on imaging.
If symptomatic, p...
Weight loss of at least 5-7% of body weight helps stabilize steatosis. Grea...
All patients should be tested for hepatitis A and B and vaccinated, if not immune.
Consider screening patients with NASH cirrhosis for hepatocellular carcinoma acc...
K75.81 Nonalcoholic steatohepatitis (NASH)
K76.0 Fatty (change of) liver, not elsewhere classified
442685003 nonalcoholic steatohepatitis (disorder)
197315008 Non-alcoholic fatty liver (...
The prevalence of NAFLD and NASH is higher in patients with metabolic syndrome or any one of its components (diabetes, obesity, hypertriglyceridemia).
Liver biopsy is the gold standard ...
Sign up for a 10-day FREE Trial now and receive full access to all content.